Almira Blazek-Welsh;Aniko Takacs-Cox;Admir Purac;I. David MacDonald;Nancy Harrison
发明人:
I. David MacDonald,Nancy Harrison,Aniko Takacs-Cox,Admir Purac,Almira Blazek-Welsh
申请号：
US13811772
公开号：
US20130142847A1
申请日:
2011.07.27
申请国别(地区):
US
年份:
2013
代理人:
摘要：
Provided herein are compositions and methods to enhance the absorption of S-adenosylmethionine (SAMe) and methods of treating various disorders or diseases using non-parenteral SAMe formulations with enhanced-absorption and improved bioavailability. In certain embodiments, the enhanced bioavailability formulations provided herein may be used to treat a variety of diseases or disorders, such as for example, psychiatric disorders including, generalized anxiety disorder, obsessive compulsive disorder, post traumatic stress disorder, panic disorder, depressive disorders (e.g. major clinical depression) and dysthymia； as well as treating liver disorders, cancer, autoimmune disorders, inflammatory disorders, joint disorders, gastrointestinal disorders and cardiovascular disease.
